封关首日第一批经"二线口岸"货物通关 多家加工增值企业货物顺利验放 海南日报海口12月18日讯(海南日报全媒体记者 曹马志 通讯员 康明乐)12月18日海南自由贸易港封 关运作首日，第一批经"二线口岸"货物通关，主要包括经"二线口岸"进入内地加工增值免关税货物。这 是海南日报全媒体记者从海口海关获悉的。 借助加工增值免关税政策，企业进口原料经加工增值后内销，显著降低关税成本，提升产品市场竞 争力。"海关在封关前就给我们进行了培训，让我们熟悉系统操作，今天通关很顺畅。"海南维力医疗科 技开发有限公司相关负责人说，该企业进口天然乳胶等原料，在海南加工成一次性乳胶导尿管，实现 30%以上加工增值，免关税销往国内市场。 据悉，需要办理"二线"通关业务的企业通过中国(海南)国际贸易"单一窗口"申报后，系统数据会发 送至海南自由贸易港海关智慧监管平台，该平台自动与港口(机场)作业系统进行对接。"当车辆经过海 关监管通道预判卡口时，没有被布控的，可直接放行离岛，提高货车通关效率;被布控的，会引导车辆 前往海关集中查验场进行查验，查验正常，可以正常通行，查验异常，海关做进一步处置。"海口海关 所属海口港海关相关负责人说。 1 ...

Core Viewpoint - Company Aihuilong (688575.SH) has been recognized as a national-level manufacturing champion enterprise, specifically for its autoimmune disease diagnostic products, which reflects the company's technological and quality excellence [1] Group 1: Recognition and Impact - The inclusion in the ninth batch of national-level manufacturing champion enterprises is a recognition of the company's product technology and quality [1] - This recognition enhances the company's industry position and demonstrates its independent innovation capabilities [1] - The acknowledgment is expected to strengthen the brand influence and market competitiveness of the company's products, leading to positive operational impacts [1]

Group 1 - The company intends to reappoint Zhongqin Wanxin Certified Public Accountants (Special General Partnership) as its auditing firm for the year 2025 [3][14][15] - Zhongqin Wanxin has been established since December 2013 and holds qualifications for auditing securities and futures-related businesses [3][5] - The firm reported a total revenue of 476 million yuan for 2024, with auditing business revenue of 407 million yuan and securities futures business revenue of 108 million yuan [5][6] Group 2 - The company has decided to change its accounting estimates regarding the capitalization of research and development expenditures, effective from January 1, 2025 [19][20][24] - The change aims to better reflect the company's financial status and operational results, aligning with the actual conditions of its R&D activities [22][26] - The company will not retroactively adjust previously disclosed financial statements due to this change, ensuring no impact on past financial results [25][36] Group 3 - The company has also announced a change in its accounting policy based on the Ministry of Finance's new interpretations, which will not significantly affect its financial status or cash flows [31][36] - The new policy will be implemented from January 1, 2024, and is aimed at improving the accuracy of financial reporting [35][36] - The company has completed a share buyback program, reducing its total share capital from 581,011,346 shares to 571,424,768 shares [37][38]